Clinical Effect, Analysis of Amoxicillin Clavulanate Potassium Combined with Shenling Baizhu Powder in the Treatment of Gastric Ulcer with Helicobacter pylori Infection

被引:0
|
作者
Wang, Ying [1 ]
Hou, Shu [1 ]
机构
[1] Chengdu Third Peoples Hosp, Phys Examinat Ctr, Dept Gastroenterol, Chengdu 610000, Sichuan, Peoples R China
关键词
Amoxicillin-clavulanate potassium; Shenling Baizhu powder; gastric ulcer; Helicobacter pylori; clinical efficacy;
D O I
10.36468/pharmaceutical-sciences.spl.500
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We attempt to investigate the improvement of clinical efficacy of amoxicillin-clavulanate potassium combined with Shenling Baizhu powder in treating gastric ulcer patients with Helicobacter pylori infection and the effect on related serum indexes. We selected 90 patients with gastric ulcer complicated with Helicobacter pylori infection in our hospital from January 2019 to May 2021 and randomly divided them into observation group (45 cases treated with amoxicillin clavulanate potassium combined with Shenling Baizhu powder) and control group (45 cases treated with amoxicillin-clavulanate potassium), compared both groups on the clinical effective rate and Helicobacter pylori eradication rate (per-protocol analysis) before and after treatment, the serum mucosal cytokines (vascular endothelial growth factor, epidermal growth factor, cyclooxygenase-2), matrix metalloproteinase and infection indicators (procalcitonin, C-reactive protein, interleukin-6) concentration level changes. After treatment, observation group possessed remarkably higher serum levels of vascular endothelial growth factor, epidermal growth factor and cyclooxygenase-2 than control group (p<0.05); it possessed remarkably lower procalcitonin, C-reactive protein and interleukin-6 serum levels than control group (p<0.05); and it possessed remarkably lower matrix metalloproteinase-7, matrix metalloproteinase-9 and matrix metalloproteinase plasma levels than control group (p<0.05); after per-protocol analysis, Helicobacter pylori radical cure rate of observation group (86.67 %) was remarkably higher than control group (66.67 %) (p<0.05). Amoxicillin-clavulanate potassium combined with Shenling Baizhu powder can significantly improve the clinical efficacy of gastric ulcer complicated with Helicobacter pylori infection, increase the clearance rate of Helicobacter pylori, increase the level of cellular and mucosal cytokines in serum and reduce the level of serum cytokines. The concentration levels of procalcitonin, C-reactive protein and interleukin-6 can provide clinical guidance value for effectively treating gastric ulcer with Helicobacter pylori infection.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 50 条
  • [1] Analysis on the Clinical Effect of Shenling Baizhu San Combined with Routine Treatment on Bacterial Pneumonia in Children
    Jinli FENG
    Cheng ZHANG
    Houjun CHEN
    Ziliang CHEN
    Yongfeng CHEN
    Zhiguang WU
    [J]. Medicinal Plant, 2020, (03) : 84 - 86
  • [2] Effect of Amoxicillin and Clavulanate Potassium Combined with Bazhengsan on Pediatric Urinary Tract Infection
    Zhang, Shengjun
    Wang, Zhenghua
    Xu, Guoping
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [3] Treatment of Helicobacter pylori infection with different doses of clarithromycin combined with amoxicillin and lansoprazole
    Costa, F
    Amato, G
    Belcari, C
    Bellini, M
    Tumino, E
    Spataro, M
    Lambresa, L
    Manghetti, M
    Ciccorossi, P
    Maltinti, G
    Marchi, S
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A94 - A94
  • [4] Development and characterization of amoxicillin loaded floating microballoons for the treatment of Helicobacter pylori induced gastric ulcer
    Awasthi, Rajendra
    Kulkarni, Giriraj T.
    [J]. ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 8 (03) : 174 - 180
  • [5] Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients
    Meining, A
    Höchter, W
    Weingart, J
    Sommer, A
    Klann, H
    Simon, T
    Huber, F
    Bolle, KH
    Hatz, R
    Fischer, G
    Lehn, N
    Stolte, M
    Bayerdörffer, E
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (01) : 49 - 54
  • [6] Clinical analysis of the effect of helicobacter pylori infection on immune function in children with peptic ulcer
    Teng, Yongnan
    Dong, Qingwei
    Zhang, Sisi
    Chen, Songsong
    Li, Chen
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (06) : 1063 - 1066
  • [7] Effect of Helicobacter pylori infection on phospholipids of gastric mucosa in patients with peptic ulcer
    Koyama, T
    Tadano, J
    Kawasaki, S
    Ohyama, T
    Sakata, H
    Iwakiri, R
    Fujimoto, K
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A162 - A162
  • [8] Helicobacter pylori infection, effect on gastric histology and clinical outcome
    Salih, BA
    Bughrara, FA
    [J]. SAUDI MEDICAL JOURNAL, 2004, 25 (12) : 2053 - 2054
  • [9] LANSOPRAZOLE VERSUS LANSOPRAZOLE PLUS AMOXICILLIN TREATMENT FOR ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH GASTRIC-ULCER
    SUGIYAMA, T
    HISANO, K
    OCHIAI, T
    FUJITA, N
    KOBAYASHI, T
    YABANA, T
    KUROKAWA, I
    YACHI, A
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 : S104 - S106
  • [10] The effect of treatment of Helicobacter pylori infection gastric mucosal plasminogen activators
    Gotz, JM
    Ravensbergen, JW
    Verspaget, HW
    Biemond, I
    Sier, CFM
    Offerhaus, GJA
    Lamers, CBHW
    Veenendaal, RA
    [J]. FIBRINOLYSIS, 1996, 10 : 85 - 89